Document is current
Any future updates will be listed below
-
Authors
Motazedian, Ali
Dawson, Mark A. https://orcid.org/0000-0002-5464-5029
- License Information
-
More Information
Article History
First Online: 9 April 2021
Competing interests
: M.A.D. has been a member of advisory boards for GlaxoSmithKline, CTX CRC, Storm Therapeutics, Celgene and Cambridge Epigenetix. The M.A.D. laboratory received research funding from CTx CRC.
